Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension

You may be eligible if

• more or equal than 18 years old,
• patient with triple antihypertensive therapy (maximum tolerated dose) with a diuretic, except for anuric patients, and without modification treatment:
• in the last two months,
• expected in the next three months,
• renal transplanted patients with native kidneys followed for hypertension before transplant, and having a arterial systolic pressure ≥ 160 mmHg on the average of 3 measurements taken during the screening consultation and during at least one previous consultation OR
• chronic renal failure patient with dialysis and having a arterial systolic pressure ≥ 160 mmHg on the average of 3 measurements taken during the screening consultation and during at least one previous consultation
• patient affiliated to social security or similarly regime
• patient who signed the consent to participate in the study
• renal artery anatomy against-indicating the procedure including:
• 3 homolateral renal arteries
• kidney surgery including bypass surgery or renal artery reimplantation
• volume-dependent type of hypertension
• secondary hypertension (not included nephropathy)
• orthostatic hypotension associated with symptoms during the previous year
• medical history including:
• * acute coronary syndrome, unstable angina, stroke within 6 months preceding the period of inclusion,
• * surgery scheduled on the kidney, the renal arteries or the retroperitoneum during patient participation in the study period
• * chronic alcoholism
• anticoagulants or antiplatelet agents for which a therapeutic window can not be considered (except aspirin dose less than or equal to 160mg / day)
• contraindication to the realization of an MRI
• included in another trial assessing a medicament or a medical device or a surgical procedure
• protected person referred to in Articles L1121-5 to L1121-8 of the Code of Public Health